Cardiovascular Outcomes in African Americans with Sickle Cell Trait and Chronic Kidney Disease

Kabir O Olaniran1, Nwamaka D Eneanya2, Andrew S Allegretti3

  • 1Division of Nephrology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA, kolaniran@mgh.harvard.edu.

Insights

Sickle cell trait (SCT) increases coronary artery disease (CAD) risk in African American men with chronic kidney disease (CKD). This risk mirrors that seen in sickle cell disease (SCD) patients, highlighting a sex-specific cardiovascular impact.

Area of Science:

  • Nephrology
  • Cardiology
  • Genetics

Background:

  • Sickle cell trait (SCT) is prevalent in African Americans and often considered benign.
  • Recent studies link SCT to increased risks of chronic kidney disease (CKD) and cardiovascular disease (CVD).
  • Existing knowledge on SCT is largely derived from sickle cell disease (SCD) data, where sex influences outcomes.

Purpose of the Study:

  • To investigate the effect of SCT on cardiovascular risk in African American patients with CKD.
  • To examine the interaction between SCT and sex regarding cardiovascular risk in this population.

Main Methods:

  • A retrospective cohort study involving 217 African American CKD patients with SCT and 404 matched controls without SCT.
  • Data collected from January 2005 to December 2017 across two centers.
  • Primary outcomes included incident coronary artery disease (CAD), incident stroke, and all-cause mortality, with analysis of sex-SCT interaction.

Main Results:

  • No significant differences in primary outcomes were observed between SCT patients and controls overall.
  • A significant interaction between SCT and sex was found for CAD risk (p < 0.01).
  • Stratified analysis revealed no increased CAD risk in females, but a significantly elevated risk in males with SCT (HR 2.13; 95% CI 1.17-3.86).

Conclusions:

  • Sickle cell trait is associated with increased coronary artery disease risk specifically in African American males with CKD.
  • This observed risk pattern in males with SCT parallels findings in males with sickle cell disease.
  • Further research is warranted to validate these sex-specific cardiovascular findings in SCT.
Abstract

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
728
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
646
Multiple Allele Traits01:49

Multiple Allele Traits

The Concept of Multiple Allelism
38.1K
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
467
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
388
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
570